These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29335316)

  • 41. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
    Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M; Mata P; Parhofer KG; Raal FJ; Santos RD; Sijbrands EJ; Simpson WG; Sullivan DR; Susekov AV; Tomlinson B; Wiegman A; Yamashita S; Kastelein JJ
    Int J Cardiol; 2014 Feb; 171(3):309-25. PubMed ID: 24418289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Familial hypercholesterolemia in children].
    Andersen S
    Tidsskr Nor Laegeforen; 1996 Jan; 116(2):299-300. PubMed ID: 8633344
    [No Abstract]   [Full Text] [Related]  

  • 43. The hinterland of familial hypercholesterolaemia: what do we not know?
    Wierzbicki AS; Watts GF
    Curr Opin Lipidol; 2015 Dec; 26(6):475-83. PubMed ID: 26780001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Homozygous familial hypercholesterolaemia: Spanish adaptation of the position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Consensus document of the Spanish Society of Arteriosclerosis (SEA) and Familial Hypercholesterolaemia Foundation (FHF)].
    Ascaso JF; Mata P; Arbona C; Civeira F; Valdivielso P; Masana L
    Clin Investig Arterioscler; 2015; 27(2):80-96. PubMed ID: 25757840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association.
    Gidding SS; Champagne MA; de Ferranti SD; Defesche J; Ito MK; Knowles JW; McCrindle B; Raal F; Rader D; Santos RD; Lopes-Virella M; Watts GF; Wierzbicki AS;
    Circulation; 2015 Dec; 132(22):2167-92. PubMed ID: 26510694
    [No Abstract]   [Full Text] [Related]  

  • 46. Impact of the integrated guidance on the care of familial hypercholesterolaemia.
    Arai H; Ding YA; Yamashita S
    J Atheroscler Thromb; 2014; 21(4):366-7. PubMed ID: 24573014
    [No Abstract]   [Full Text] [Related]  

  • 47. Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays.
    Reiman A; Pandey S; Lloyd KL; Dyer N; Khan M; Crockard M; Latten MJ; Watson TL; Cree IA; Grammatopoulos DK
    Ann Clin Biochem; 2016 Nov; 53(6):654-662. PubMed ID: 26748104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combating high cholesterol. Interview by Ann Shuttleworth.
    Pottle A
    Nurs Times; 2006 Dec 12-2007 Jan 1; 102(50):20-1. PubMed ID: 17212291
    [No Abstract]   [Full Text] [Related]  

  • 49. Screening for familial hypercholesterolaemia.
    Calonge N; Guirguis-Blake J
    BMJ; 2007 Sep; 335(7620):573-4. PubMed ID: 17884865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The program for detection and treatment of patients with familial hypercholesterolemia (MedPed FH) in the Czech Republic].
    Freiberger T; Soska V; Kuhrová V; Stejskal J
    Cas Lek Cesk; 2000 Apr; 139(7):195-6. PubMed ID: 10916204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypercholesterolaemia: management and nursing implications.
    Babb Y; Eyre C
    Paediatr Nurs; 2005 Mar; 17(2):35-8. PubMed ID: 15793988
    [No Abstract]   [Full Text] [Related]  

  • 52. Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum.
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior-Waluś B; Imiela J; Jankowski P; Kłosiewicz-Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T
    Pol Arch Med Wewn; 2013; 123(1-2):7-10. PubMed ID: 23449188
    [No Abstract]   [Full Text] [Related]  

  • 53. Portacaval shunt in familial hypercholesterolaemia.
    Mitchell SC
    Lancet; 1983 Jan; 1(8317):193. PubMed ID: 6130242
    [No Abstract]   [Full Text] [Related]  

  • 54. An update on familial hypercholesterolaemia.
    Ose L
    Ann Med; 1999 Apr; 31 Suppl 1():13-8. PubMed ID: 10342495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of European and US guidelines for familial hypercholesterolaemia.
    Reiner Ž
    Curr Opin Lipidol; 2015 Jun; 26(3):215-20. PubMed ID: 25943839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia.
    Datta BN; McDowell IF; Rees A
    Curr Opin Lipidol; 2010 Aug; 21(4):366-71. PubMed ID: 20613514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High specificity makes DNA screening the method of choice for diagnosis of familial hypercholesterolaemia.
    Kotze MJ
    S Afr Med J; 2001 Dec; 91(12):1042. PubMed ID: 11845598
    [No Abstract]   [Full Text] [Related]  

  • 58. Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.
    Marks D; Thorogood M; Neil SM; Humphries SE; Neil HA
    J Med Screen; 2006; 13(3):156-9. PubMed ID: 17007658
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic unexceptionalism: clinician accounts of genetic testing for familial hypercholesterolaemia.
    Will CM; Armstrong D; Marteau TM
    Soc Sci Med; 2010 Sep; 71(5):910-7. PubMed ID: 20591544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of homozygous familial hypercholesterolaemia.
    Sharma SK; Kaushal R; Chattopadhyay TK
    Br Med J (Clin Res Ed); 1985 Dec; 291(6509):1644. PubMed ID: 3935218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.